Boothbay Fund Management, LLC Geron Corp Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.99 - $1.6 $18,893 - $30,534	-19,084 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.22 - $1.72 $23,282 - $32,824	19,084 New	19,084 $23,000
Q3 2021 Nov 15, 2021	SELL	$1.2 - $1.5 $14,071 - $17,589	-11,726 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.25 - $1.83 $14,657 - $21,458	11,726 New	11,726 $17,000
Q4 2018 Feb 14, 2019	SELL	$0.98 - $1.85 $16,743 - $31,607	-17,085 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$1.76 - $6.38 $30,069 - $109,002	17,085 New	17,085 $30,000

274

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.32B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.